Novavax (NVAX)

Company Description

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates.


 

COMPANY ADDRESS
9920 Belward Campus Drive
Rockville, Maryland 20850
United States

COMPANY PHONE
240-268-2000

COMPANY WEBSITE



Get BioInvest's perspective on Novavax's CEO


Latest Company News